Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia A”

281 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 281 results

Not applicableUnknownNCT00324493
What this trial is testing

Musculoskeletal Function in Hemophilia

Who this might be right for
Hemophilia
Christian Medical College, Vellore, India 250
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableStudy completedNCT04953000
What this trial is testing

Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 94
Not applicableStudy completedNCT03299699
What this trial is testing

Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia

Who this might be right for
Severe Haemophilia
Assistance Publique Hopitaux De Marseille 30
Not applicableStudy completedNCT01318707
What this trial is testing

Biomarkers Serum Collection Methodology Pilot Study

Who this might be right for
Hemophilia A
Georgetown University 20
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Early research (Phase 1)Looking for participantsNCT06703606
What this trial is testing

Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Who this might be right for
Severe Hemophilia A
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01945593
What this trial is testing

BAX 855 Continuation

Who this might be right for
Hemophilia A
Baxalta now part of Shire 218
Large-scale testing (Phase 3)Study completedNCT01233258
What this trial is testing

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 80
Large-scale testing (Phase 3)Study completedNCT01311648
What this trial is testing

BAY81-8973 Pediatric Safety and Efficacy Trial

Who this might be right for
Haemophilia A
Bayer 94
Testing effectiveness (Phase 2)UnknownNCT04592692
What this trial is testing

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Who this might be right for
Hemophilia A With Inhibitor
Ascension Healthcare Development Limited 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04644575
What this trial is testing

Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 261
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07226206
What this trial is testing

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 5
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Post-approval studies (Phase 4)Study completedNCT04085458
What this trial is testing

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

Who this might be right for
Hemophilia A
Bayer 32
Not applicableUnknownNCT04550988
What this trial is testing

Sonography and Haemophilia

Who this might be right for
SonographyHaemophilia
University Hospital, Bonn 5
Large-scale testing (Phase 3)Study completedNCT05147662
What this trial is testing

Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

Who this might be right for
Treatment of BleedingProphylaxis of BleedingHemophilia A+1 more
Bayer 36
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Not applicableEnrolling By InvitationNCT06816953
What this trial is testing

Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis

Who this might be right for
Hemophilia A
Chulalongkorn University 19
Large-scale testing (Phase 3)Study completedNCT01181128
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Bioverativ Therapeutics Inc. 165
Load More Results